With new stories hitting the headlines every week, the Foreign Corrupt Practices Act and other Anti-Bribery legislation worldwide continues to be a hot topic for businesses operating internationally.  Just last week, Pfizer settled a case opened by the US Department of Justice for $60 million, admitting that sales representatives at their subsidiary, Wyeth, bribed hospital administrators (considered foreign officials as representatives of state-run medical facilities) in several European and Asian countries.  In this case, Pfizer reported the misconduct to the SEC and DOJ, according to company representatives, as soon as they were made aware of the situation.

Resources Global Professionals wants to keep you informed on the most recent developments in FCPA enforcement actions, so that you can learn from the hard lessons others have already faced.  Join Thomas Robert Fox, FCPA expert, and the Resources Global team on Monday, August 27th at Noon ET (9 AM PT) for The Foreign Corrupt Practices Act: New Developments in 2012.

CPE is available for participating attendees.  Register today to secure your spot.

Let policyIQ help you manage your Anti-Bribery and Anti-Corruption Compliance Programs

One of the key lessons that has been consistent throughout all of the FCPA enforcement actions is that organizations with a strong anti-corruption compliance and training program will fare much better when subjected to DOJ or SEC investigations.  policyIQ can help your organization implement and maintain that program, with comprehensive audit trails, policy sign-offs and reporting of gifts or entertainment expenses.

Interested in learning more?  Check out our series of blog posts from the past several years dealing with FCPA and Anti-Corruption compliance.  Please contact us if you are interested in implementing your Anti-Corruption compliance program into policyIQ!